Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1978 1
1990 1
1992 1
1993 1
1995 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Possible case of procainamide-induced intrahepatic cholestatic jaundice.
Chuang LC, Tunier AP, Akhtar N, Levine SM. Chuang LC, et al. Ann Pharmacother. 1993 Apr;27(4):434-7. doi: 10.1177/106002809302700407. Ann Pharmacother. 1993. PMID: 8477118 Review.
DISCUSSION: Only five cases of procainamide-induced liver abnormalities have been previously reported; these included granulomatous hepatitis and intrahepatic cholestasis. ...CONCLUSIONS: Procainamide-induced liver dysfunction can occur from one day to …
DISCUSSION: Only five cases of procainamide-induced liver abnormalities have been previously reported; these included granulom …
Clinical consequences of polymorphic acetylation of basic drugs.
Drayer DE, Reidenberg MM. Drayer DE, et al. Clin Pharmacol Ther. 1977 Sep;22(3):251-8. doi: 10.1002/cpt1977223251. Clin Pharmacol Ther. 1977. PMID: 19187
Genetic slow acetylators are more likely than rapid acetylators to experience the following adverse drug reactions: (1) earlier development of procainamide-induced antinuclear antibody; (2) earlier and more frequent development of procainamide-induced systemi …
Genetic slow acetylators are more likely than rapid acetylators to experience the following adverse drug reactions: (1) earlier devel …
Testing of metoclopramide and procainamide for their ability to induce genotoxic effects in cultured mammalian cells.
Martelli A, Campart GB, Canonero R, Mattioli F, Brambilla G. Martelli A, et al. Toxicol Appl Pharmacol. 1995 Apr;131(2):185-91. doi: 10.1006/taap.1995.1060. Toxicol Appl Pharmacol. 1995. PMID: 7716760
In subtoxic concentrations neither MCA (from 0.10 to 0.32 mM) nor PCA (from 0.18 to 0.56 mM) induced DNA fragmentation and repair in primary cultures of metabolically competent rat and human hepatocytes. ...These results suggest that of the two benzamides tested only MCA s …
In subtoxic concentrations neither MCA (from 0.10 to 0.32 mM) nor PCA (from 0.18 to 0.56 mM) induced DNA fragmentation and repair in …
Hypersensitivity reaction associated with acute hepatic dysfunction following a single intravenous dose of procainamide.
Worman HJ, Ip JH, Winters SL, Tepper DC, Gomes AJ. Worman HJ, et al. J Intern Med. 1992 Oct;232(4):361-3. doi: 10.1111/j.1365-2796.1992.tb00599.x. J Intern Med. 1992. PMID: 1402640
This case should alert physicians to potential hepatotoxic reactions to procainamide, particularly with the increasing popularity of cardiac electrophysiological testing, during which this drug is commonly used....
This case should alert physicians to potential hepatotoxic reactions to procainamide, particularly with the increasing popularity of cardiac …
Intrahepatic cholestasis due to hypersensitivity reaction to procainamide.
Ahn CS, Tow DE. Ahn CS, et al. Arch Intern Med. 1990 Dec;150(12):2589-90. Arch Intern Med. 1990. PMID: 2244779
Hypersensitivity reactions to procainamide involving liver dysfunction are rare. We describe a patient who developed liver dysfunction after procainamide administration, manifested by fever, jaundice, elevated bilirubin concentration, and alkaline phosphatase concen …
Hypersensitivity reactions to procainamide involving liver dysfunction are rare. We describe a patient who developed liver dys …